Chronic Kidney Disease

The AJMC® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.

Latest News

The investigators concluded that epidemiological inequity in CKD and cardiovascular disease remains an important issue that requires further study of potential interventions. | Image credit: filins - stock.adobe.com
Disparities in CKD-Associated Cardiac Arrest Across Demographics

March 22nd 2025

Non-Hispanic Black populations face the highest risk of death from chronic kidney disease (CKD)–associated cardiac arrest, a study found.

Naz Urooj | Image credit: Interwell Health
Contributor: Data, Education, and Community: The Winning Formula for Addressing SDOH for Kidney Care Patients

March 21st 2025

Image Credit: selote - stock.adobe.com
New Guideline Updates to Slow CKD Progression and Reduce Cardiovascular Risk

March 10th 2025

Doctor holding card that says furosemide | Image credit: MQ-Illustrations – stock.adobe.com
FDA Expands Furosemide Injection Label to Treat Edema in CKD

March 7th 2025

Yo-Yo Dieting | Image Credit: © Karen Roach-stock.adobe.com
Weight Fluctuation Threatens Kidney Health in Type 1 Diabetes

February 4th 2025

Population Health Management of Chronic Kidney Disease (CKD)

An expert panel discusses chronic kidney disease (CKD), its impact on cardiovascular disease, and the methods of treatment used on the patient populations.

Panel members

More News

Future of CKD Care Remains Focused on Value, Even With CMMI Delay
May 1st 2021

Future of CKD Care Remains Focused on Value, Even With CMMI Delay

Allison Inserro
Although the Center for Medicare and Medicaid Innovation (CMMI) has delayed the start of payment models for kidney care, one dialysis provider says it remains committed to the concept.
FDA Approves Oral Dapagliflozin to Slow Kidney Decline
April 30th 2021

FDA Approves Oral Dapagliflozin to Slow Kidney Decline

Allison Inserro
Last year, a data monitoring committee halted the DAPA-CKD trial when it found the evidence of efficacy was overwhelming, after it was shown the trial met all its primary and secondary end points for patients with chronic kidney disease, with and without type 2 diabetes.
Brain MRI
April 30th 2021

Progressive CKD Increases Prevalence, Severity of Cerebral Small Vessel Disease

Larry Hanover
New research highlights a relationship between chronic kidney disease (CKD) and cerebral small vessel disease.
Kidneys
April 21st 2021

Quality of Life Similar Between Patients With CKD Receiving Hemodialysis, CAPD

Larry Hanover
Quality of life is similar between patients with chronic kidney disease (CKD) undergoing hemodialysis and those having continuous ambulatory peritoneal dialysis (CAPD) in the hospital.
Kidney disease diagnosis
April 15th 2021

Higher Degree of Frailty From DKD May Be Linked to Delirium, Cognitive Impairment

Larry Hanover
Study results indicate a possible relationship between diabetic kidney disease (DKD) and frailty and risk of subsequent delirium and cognitive impairment.
Patients With ESKD Suffered Severe, Disparate Mortality in Early Phase of Pandemic
April 10th 2021

Patients With ESKD Suffered Severe, Disparate Mortality in Early Phase of Pandemic

Larry Hanover
The findings illustrate the importance of prioritizing COVID-19 vaccinations for patients on dialysis.
Home based dialysis may benefit patients with anemia in end stage kidney disease
April 2nd 2021

New Advances May Ease Path to Managing Anemia in Kidney Disease at Home, Report Says

Larry Hanover
Anemia, which occurs in over 50% of patients with end-stage kidney disease, should not be considered an obstacle to home dialysis, according to a new report.
Patients on dialysis can get a COVID-19 vaccination at their treatment center
March 25th 2021

Dialysis Centers Included in Plan to Expand Access to COVID-19 Vaccines

Allison Inserro
The announcement allowing the administration of COVID-19 vaccines in dialysis centers is part of a larger $10 billion investment, largely funded by the American Rescue Plan, to expand access.
Study Illustrates Characteristics of Patients With ESRD Using Emergency Departments
March 22nd 2021

Study Illustrates Characteristics of Patients With ESRD Using Emergency Departments

Allison Inserro
Patient data about emergency department use by this population is limited, the authors said.
Review Highlights Therapeutic Efforts to Delay CKD Progression
March 20th 2021

Review Highlights Therapeutic Efforts to Delay CKD Progression

Larry Hanover
Improved understanding of the early mechanisms of chronic kidney disease (CKD) may be the next step in efforts to delay or reverse disease progression.
Shifting Dialysis Away From Employer-Based Coverage Cost Medicare $3 Billion, Study Finds
March 18th 2021

Shifting Dialysis Away From Employer-Based Coverage Cost Medicare $3 Billion, Study Finds

Allison Inserro
The study examined the cost to Medicare when patients with end-stage renal disease switched from their employer-based health insurance to Medicare between 2007 and 2017 before the end of the 30-month coordination period.
Study Recommends Rate of Physical Activity for Patients With CKD
March 12th 2021

Study Recommends Rate of Physical Activity for Patients With CKD

Larry Hanover
The study, published on World Kidney Day, is the first to report the optimal amount of activity in patients with chronic kidney disease, according to the authors.
Study Illustrates Kidney Impact After COVID-19 Resolves
March 10th 2021

Study Illustrates Kidney Impact After COVID-19 Resolves

Allison Inserro
More than a year into the COVID-19 pandemic, a new study suggests that individuals recovering from acute kidney injury stemming from COVID-19 will require kidney monitoring after they leave the hospital.
Study Describes AKI Incidence in Children With COVID-19, MIS-C
March 6th 2021

Study Describes AKI Incidence in Children With COVID-19, MIS-C

Allison Inserro
A retrospective study looking at pediatric patients hospitalized in 4 New York hospitals in 2020 with COVID-19 or multisystem inflammatory syndrome in children (MIS-C) found that acute kidney injury (AKI) occurred in 11.8% of patients.
kidney picture
March 5th 2021

Kidney Transplants Benefit Patients With SCD, But Few Have Chance to Receive Them

Allison Inserro
Despite benefitting from organ transplants similarly to other patients with kidney failure, a new study found patients with kidney failure associated with sickle cell disease (SCD) are less likely to receive transplants.
Genetic Picture Emerges of Polycystic Kidney Disease in Ireland
February 27th 2021

Genetic Picture Emerges of Polycystic Kidney Disease in Ireland

Larry Hanover
Cutting-edge genetic tools diagnosed 83% of Irish patients with polycystic kidney disease (PKD), identified 36 novel variants, and discovered that seemingly unrelated individuals with the same variant likely inherited it from a common ancestor.
Caring for kidneys
February 25th 2021

Slowing CKD, Adherence to Care Guidelines Need to Improve, Study Says

Larry Hanover
Adherence to guidelines for slowing chronic kidney disease is low, with substantial variation among the United States and other countries.
Review Suggests Mortality Risk Factors for Patients on Dialysis
February 20th 2021

Review Suggests Mortality Risk Factors for Patients on Dialysis

Larry Hanover
Older patients are at greater risk of death in the earliest stages of dialysis, while females possibly are at a higher risk than men, a review of studies found.
Even Patients With Mild CKD Have Higher Hospitalization Rates, Study Says
February 20th 2021

Even Patients With Mild CKD Have Higher Hospitalization Rates, Study Says

Larry Hanover
Patients with chronic kidney disease (CKD) healthy enough not to have seen a specialist have higher hospitalization rates than the general population, according to a recent study.
Palliative Care in ESRD Is Possible With Right Planning, Education, Tools
February 12th 2021

Palliative Care in ESRD Is Possible With Right Planning, Education, Tools

Allison Inserro
Planning and education can help create systemwide change in order to implement greater use of advance care planning and palliative care for those with end-stage renal disease (ESRD).
Brandi Riddle
February 6th 2021

Brandi Riddle Discusses Technology’s Role in the Future of Kidney Care

Brandi Riddle, chief financial officer at Strive Health, discussed the role technology and predictive analytics will play in changing kidney care in the future.
A Look at Recent Novel Iron Replacement Therapies for the Treatment of Anemia in CKD
February 6th 2021

A Look at Recent Novel Iron Replacement Therapies for the Treatment of Anemia in CKD

Jaime Rosenberg
Noting each of their benefits, the researchers also caution that to better characterize their safety and efficacy, there’s a need for further investigation among larger patient pools.
Study Highlights Suboptimal Prescribing of Anemia Medication in Patients With NDD-CKD
February 4th 2021

Study Highlights Suboptimal Prescribing of Anemia Medication in Patients With NDD-CKD

Jaime Rosenberg
Data from nearly 3000 patients across multiple countries with the disease showed that undertreatment was most notable among patient with hemoglobin (Hb) <10 g/dL.
Caring for Individuals With Kidney Disease During the Pandemic
January 20th 2021

Caring for Individuals With Kidney Disease During the Pandemic

Mary Dittrich, MD
Nephrologist Mary Dittrich, MD, the chief medical officer and executive vice president of U.S. Renal Care as well as cofounder and partner of Boise Kidney & Hypertension Institute, discusses how to keep patients safe while providing high-quality kidney care during the coronavirus disease 2019 pandemic.
Graphic depicting lineage
January 16th 2021

Family History, Genetics May Help to Predict, Detect Early-Stage CKD

Skylar Jeremias
A population-based study from the Netherlands showed that individuals with had at least 1 direct relative affected with chronic kidney disease (CKD), suggesting that biomarkers for CKD can aid in detecting the early stages of the disease.
Kidney graphic
January 8th 2021

FDA Grants Priority Review to Dapagliflozin for CKD

Skylar Jeremias
The FDA decision on dapaglifozin for CKD is expected in the second quarter of 2021.
Large Swedish Study Says Stopping RAS Inhibitors Leads to Worse CKD Outcomes
January 3rd 2021

Large Swedish Study Says Stopping RAS Inhibitors Leads to Worse CKD Outcomes

AJMC Staff
A new study from Sweden cautions against routine discontinuation of renin-angiotensin system (RAS) inhibitors in patients with chronic kidney disease (CKD).
Dr Guofen Yan Considers Strategies for Improving CKD Outcomes in Minority Populations
December 31st 2020

Dr Guofen Yan Considers Strategies for Improving CKD Outcomes in Minority Populations

Slowing progression of chronic kidney disease can help mitigate adverse outcomes in minority populations, said Guofen Yan, PhD, associate professor of biostatistics in the Department of Public Health Sciences at the University of Virginia School of Medicine.
Dr Kunihiro Matsushita Lays Out the Benefits of the CKD Patch Approach
December 31st 2020

Dr Kunihiro Matsushita Lays Out the Benefits of the CKD Patch Approach

This approach allows clinicians to keep using existing prediction models and incorporate chronic kidney disease (CKD) data seamlessly to calibrate patients' risks, said Kunihiro Matsushita, MD, an associate professor in the Department of Epidemiology and Division of Cardiology at Johns Hopkins University.
Top 5 Most-Read Chronic Kidney Disease Articles of 2020
December 28th 2020

Top 5 Most-Read Chronic Kidney Disease Articles of 2020

Allison Inserro
Two story lines predominated renal news in 2020: coronavirus disease 2019's effect on the kidneys and the overwhelming benefits of sodium-glucose cotransporter 2 inhibitors for those with chronic kidney disease and type 2 diabetes.
<1
...
3456789101112>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo